{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:51:57Z","timestamp":1770742317006,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jchromb.2022.123476","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T13:05:29Z","timestamp":1663938329000},"page":"123476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Development of an Ultra-High Performance Liquid Chromatography method for the simultaneous mass detection of tobacco biomarkers in urine"],"prefix":"10.1016","volume":"1210","author":[{"given":"Marie-Lise","family":"Colsoul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Goderniaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Vanpee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Galanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2022.123476_b0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/FTD.0b013e3181957a3b","article-title":"Methods for Quantification of Exposure to Cigarette Smoking and Environmental Tobacco Smoke: Focus on Developmental Toxicology","volume":"31","author":"Florescu","year":"2009","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2022.123476_b0010","first-page":"1668","article-title":"Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy","volume":"11","author":"Jacob","year":"2002","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.jchromb.2022.123476_b0015","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/jat\/bku059","article-title":"Reference interval determination for anabasine: a biomarker of active tobacco use","volume":"38","author":"Suh-Lailam","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2022.123476_b0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/nyas.12609","article-title":"Are E-cigarettes a safe and good alternative to cigarette smoking?","volume":"1340","author":"Rom","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jchromb.2022.123476_b0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/ntr\/ntab162","article-title":"Validation of the Wave 1 and Wave 2 Population Assessment of Tobacco and Health (PATH) Study Indicators of Tobacco Dependence Using Biomarkers of Nicotine Exposure Across Tobacco Products","volume":"24","author":"Strong","year":"2022","journal-title":"Nicotine Tob. Res."},{"key":"10.1016\/j.jchromb.2022.123476_b0030","doi-asserted-by":"crossref","unstructured":"B.L. Rostron, B. Coleman, Y.-C. Cheng, H.L. Kimmel, O. Oniyide, L. Wang, C.M. Chang, Nicotine Exposure by Device Type among Adult Electronic Nicotine Delivery System Users in the Population Assessment of Tobacco and Health Study, 2015\u20132016, Cancer Epidemiol. Biomarkers Prev. 29 (2020) 1968\u20131972. https:\/\/doi.org\/10.1158\/1055-9965.EPI-20-0317.","DOI":"10.1158\/1055-9965.EPI-20-0317"},{"issue":"3","key":"10.1016\/j.jchromb.2022.123476_b0035","doi-asserted-by":"crossref","first-page":"L425","DOI":"10.1152\/ajplung.00343.2016","article-title":"Biomarkers of exposure to new and emerging tobacco delivery products","volume":"313","author":"Schick","year":"2017","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.jchromb.2022.123476_b0040","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1021\/acs.chemrestox.5b00521","article-title":"Quantitation of the Minor Tobacco Alkaloids Nornicotine, Anatabine, and Anabasine in Smokers\u2019 Urine by High Throughput Liquid Chromatography-Mass Spectrometry","volume":"29","author":"von Weymarn","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jchromb.2022.123476_b0045","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/tobaccocontrol-2011-050298","article-title":"Assessing secondhand smoke using biological markers","volume":"22","author":"Avila-Tang","year":"2013","journal-title":"Tob Control."},{"key":"10.1016\/j.jchromb.2022.123476_b0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-540-69248-5_2","article-title":"Nicotine Chemistry, Metabolism, Kinetics and Biomarkers","author":"Benowitz","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"issue":"8","key":"10.1016\/j.jchromb.2022.123476_b0055","doi-asserted-by":"crossref","first-page":"e70938","DOI":"10.1371\/journal.pone.0070938","article-title":"Variation in trans-3\u2019-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake","volume":"8","author":"Zhu","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jchromb.2022.123476_b0060","doi-asserted-by":"crossref","unstructured":"S.D. Siegel, C. Lerman, A. Flitter, R.A. Schnoll, The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions, Cancer Prev. Res. (Phila). 13 (2020) 261\u2013272. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-19-0259.","DOI":"10.1158\/1940-6207.CAPR-19-0259"},{"key":"10.1016\/j.jchromb.2022.123476_b0065","doi-asserted-by":"crossref","unstructured":"N.L. Benowitz, J.T. Bernert, J. Foulds, S.S. Hecht, P. Jacob, M.J. Jarvis, A. Joseph, C. Oncken, M.E. Piper, Biochemical Verification of Tobacco Use and Abstinence: 2019 Update, Nicotine Tob Res. 22 (2020) 1086\u20131097. https:\/\/doi.org\/10.1093\/ntr\/ntz132.","DOI":"10.1093\/ntr\/ntz132"},{"key":"10.1016\/j.jchromb.2022.123476_b0070","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2105\/AJPH.89.5.731","article-title":"Minor tobacco alkaloids as biomarkers for tobacco use: comparison of users of cigarettes, smokeless tobacco, cigars, and pipes","volume":"89","author":"Jacob","year":"1999","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.jchromb.2022.123476_b0075","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jpba.2004.01.009","article-title":"Measuring tobacco smoke exposure: quantifying nicotine\/cotinine concentration in biological samples by colorimetry, chromatography and immunoassay methods","volume":"35","author":"Dhar","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2022.123476_b0080","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1570-0232(01)00613-4","article-title":"Determination of urinary and salivary cotinine using gas and liquid chromatography and enzyme-linked immunosorbent assay","volume":"768","author":"Kuo","year":"2002","journal-title":"J. Chromatogr. B"},{"issue":"7","key":"10.1016\/j.jchromb.2022.123476_b0085","doi-asserted-by":"crossref","first-page":"e101816","DOI":"10.1371\/journal.pone.0101816","article-title":"Validation of a LC-MS\/MS method for quantifying urinary nicotine, six nicotine metabolites and the minor tobacco alkaloids\u2013anatabine and anabasine\u2013in smokers\u2019 urine","volume":"9","author":"McGuffey","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jchromb.2022.123476_b0090","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jchromb.2009.12.018","article-title":"A novel validated procedure for the determination of nicotine, eight nicotine metabolites and two minor tobacco alkaloids in human plasma or urine by solid-phase extraction coupled with liquid chromatography-electrospray ionization-tandem mass spectrometry","volume":"878","author":"Miller","year":"2010","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2022.123476_b0095","unstructured":"Waters Corporation, Acquity QDa Detector, Separating beyond question, Bringing the power of mass detection to you, (2016). www.waters.com (accessed October 1, 2019)."},{"key":"10.1016\/j.jchromb.2022.123476_b0100","first-page":"626","article-title":"Supported Liquid Extraction (SLE): The Best Kept Secret in Sample Preparation","volume":"30","author":"Majors","year":"2012","journal-title":"LCGC North Am."},{"key":"10.1016\/j.jchromb.2022.123476_b0105","unstructured":"M. Rury, SLE, SPE and LLE \u2013 How are Those Different?, (2020). https:\/\/sampleprep.biotage.com\/expandyourhorizon\/sle-spe-and-lle-how-are-those-different (accessed March 30, 2022)."},{"key":"10.1016\/j.jchromb.2022.123476_b0110","unstructured":"European Medicines Agency (EMA), Guideline on bioanalytical method validation, (2015). https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf (accessed August 1, 2022)."},{"key":"10.1016\/j.jchromb.2022.123476_b0115","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.4155\/bio-2017-0214","article-title":"Matrix effects and application of matrix effect factor","volume":"9","author":"Zhou","year":"2017","journal-title":"Bioanalysis."},{"key":"10.1016\/j.jchromb.2022.123476_b0120","article-title":"Development and Validation of a Quantification Method of Cotinine in Urine Using Two Innovative Technologies: Supported Liquid Extraction and QDa Detection","volume":"9","author":"Colsoul","year":"2020","journal-title":"J. Diagnostic Techniques Biomed. Anal."},{"key":"10.1016\/j.jchromb.2022.123476_b0125","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/bmc.463","article-title":"Validation and application of a method for the determination of nicotine and five major metabolites in smokers\u2019 urine by solid-phase extraction and liquid chromatography-tandem mass spectrometry","volume":"19","author":"Heavner","year":"2005","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2022.123476_b0130","unstructured":"Biotage, Biotage ISOLUTE SLE+ Supported Liquid Extraction products, (2017). www.biotage.com (accessed June 11, 2018)."},{"key":"10.1016\/j.jchromb.2022.123476_b0135","series-title":"Mass Spectrometry for the Clinical Laboratory","first-page":"37","article-title":"Chapter 3 - Sample preparation techniques for mass spectrometry in the clinical laboratory","author":"Stone","year":"2017"},{"key":"10.1016\/j.jchromb.2022.123476_b0140","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1081\/JLC-100101455","article-title":"Bioanalytical Liquid Chromatographic Method Validation. a Review of Current Practices and Procedures","volume":"23","author":"Rosing","year":"2000","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jchromb.2022.123476_b0145","doi-asserted-by":"crossref","unstructured":"A.R. Tricker, Biomarkers Derived from Nicotine and its Metabolites: A Review, Contributions to Tobacco & Nicotine Research. 22 (2006) 147\u2013175. https:\/\/doi.org\/10.2478\/cttr-2013-0825.","DOI":"10.2478\/cttr-2013-0825"},{"key":"10.1016\/j.jchromb.2022.123476_b0150","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/clinchem\/48.9.1460","article-title":"Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles","volume":"48","author":"Moyer","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jchromb.2022.123476_b0155","unstructured":"Mayo Clinic Laboratories, Nicotine and Metabolites, Urine, (n.d.). https:\/\/www.mayocliniclabs.com (accessed September 23, 2019)."},{"key":"10.1016\/j.jchromb.2022.123476_b0160","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.aca.2015.02.016","article-title":"Tutorial review on validation of liquid chromatography\u2013mass spectrometry methods: Part II","volume":"870","author":"Kruve","year":"2015","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jchromb.2022.123476_b0165","first-page":"464","article-title":"Performance Qualification of HPLC Instrumentation in Regulated Laboratories","volume":"26","author":"Ciccone","year":"2008","journal-title":"LCGC North Am."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023222003804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023222003804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:09:51Z","timestamp":1761606591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023222003804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":33,"alternative-id":["S1570023222003804"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2022.123476","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an Ultra-High Performance Liquid Chromatography method for the simultaneous mass detection of tobacco biomarkers in urine","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2022.123476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123476"}}